Jaguar Health, Inc. (JAGX) vs Universe Pharmaceuticals Inc. (UPC)
A side-by-side comparison of Jaguar Health, Inc. and Universe Pharmaceuticals Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
JAGX
Jaguar Health, Inc.
$5.62HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
UPC
Universe Pharmaceuticals Inc.
$4.21HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — JAGX vs UPC
growth of $100 · dividends reinvested · last 4yJAGX -100.0% (-92.2%/yr)UPC -100.0% (-87.1%/yr)UPC compounded faster over this window
Log scale — wide-divergence pair
JAGX UPC
JAGX vs UPC: by the numbers
- •UPC is the larger company ($3M vs $2M market cap).
- •Both run net losses; UPC's is the smaller (-20.56% vs -131.76% net margin).
- •JAGX grew revenue faster over the past five years (31.88% vs -10.27% CAGR).
Metrics side by side
Valuation
| Metric | JAGX | UPC |
|---|---|---|
| P/S ratio | 0.09 | N/A |
| P/B ratio | 0.37 | 0.05 |
Profitability
| Metric | JAGX | UPC |
|---|---|---|
| Gross margin | 67.21% | 35.28% |
| Operating margin | -391.87% | -16.33% |
| Net margin | -131.76% | -20.56% |
| ROE | -554.01% | -6.54% |
| ROIC | -110.81% | -4.46% |
Growth (annualized)
| Metric | JAGX | UPC |
|---|---|---|
| Revenue CAGR (5Y) | 31.88% | -10.27% |
| Total return CAGR (5Y) | N/A | -78.19% |
Frequently asked
- Which has grown faster, JAGX or UPC?
- Over the past five years, JAGX grew revenue faster — JAGX at a 31.88% CAGR versus UPC at -10.27%.
Go deeper
Dig into the metrics
Jaguar Health ROEUniverse Pharmaceuticals ROEJaguar Health operating marginUniverse Pharmaceuticals operating marginJaguar Health revenue growthUniverse Pharmaceuticals revenue growthJaguar Health free cash flowUniverse Pharmaceuticals free cash flow
Jaguar Health & Universe Pharmaceuticals appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.